![](/img/cover-not-exists.png)
An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma
Nile, Donna L., Rae, Colin, Hyndman, Iain J., Gaze, Mark N., Mairs, Robert J.Volume:
16
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-016-2656-8
Date:
December, 2016
File:
PDF, 3.38 MB
english, 2016